BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 35343783)

  • 1. Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
    Nguyen HT; Qualizza A; Anang S; Zhao M; Zou S; Zhou R; Wang Q; Zhang S; Deshpande A; Ding H; Chiu TJ; Smith AB; Kappes JC; Sodroski JG
    J Virol; 2022 Apr; 96(8):e0166821. PubMed ID: 35343783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation.
    Zhang Z; Wang Q; Nguyen HT; Chen HC; Chiu TJ; Smith Iii AB; Sodroski JG
    J Virol; 2023 Sep; 97(9):e0059223. PubMed ID: 37696048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles.
    Nguyen HT; Wang Q; Anang S; Sodroski JG
    J Virol; 2023 Mar; 97(3):e0185722. PubMed ID: 36815832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.
    Wang Q; Esnault F; Zhao M; Chiu TJ; Smith AB; Nguyen HT; Sodroski JG
    J Virol; 2022 Apr; 96(7):e0187821. PubMed ID: 35289647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformations of Human Immunodeficiency Virus Envelope Glycoproteins in Detergents and Styrene-Maleic Acid Lipid Particles.
    Zhou R; Zhang S; Nguyen HT; Ding H; Gaffney A; Kappes JC; Smith AB; Sodroski JG
    J Virol; 2023 Jun; 97(6):e0032723. PubMed ID: 37255444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands.
    Lu M; Ma X; Reichard N; Terry DS; Arthos J; Smith AB; Sodroski JG; Blanchard SC; Mothes W
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32522853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Uncleaved and Mature Human Immunodeficiency Virus Membrane Envelope Glycoprotein Trimers.
    Castillo-Menendez LR; Witt K; Espy N; Princiotto A; Madani N; Pacheco B; Finzi A; Sodroski J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
    Zhang S; Wang K; Wang WL; Nguyen HT; Chen S; Lu M; Go EP; Ding H; Steinbock RT; Desaire H; Kappes JC; Sodroski J; Mao Y
    J Virol; 2021 Nov; 95(24):e0052921. PubMed ID: 34549974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins.
    Zou S; Zhang S; Gaffney A; Ding H; Lu M; Grover JR; Farrell M; Nguyen HT; Zhao C; Anang S; Zhao M; Mohammadi M; Blanchard SC; Abrams C; Madani N; Mothes W; Kappes JC; Smith AB; Sodroski J
    J Virol; 2020 May; 94(10):. PubMed ID: 32161177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOSIP Changes Affect Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Conformation and CD4 Engagement.
    Alsahafi N; Anand SP; Castillo-Menendez L; Verly MM; Medjahed H; Prévost J; Herschhorn A; Richard J; Schön A; Melillo B; Freire E; Smith AB; Sodroski J; Finzi A
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.
    Nguyen HT; Alsahafi N; Finzi A; Sodroski JG
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
    Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
    J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.
    Qualls ZM; Choudhary A; Honnen W; Prattipati R; Robinson JE; Pinter A
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.
    Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B
    J Virol; 2017 May; 91(10):. PubMed ID: 28250125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer.
    Zhang P; Gorman J; Geng H; Liu Q; Lin Y; Tsybovsky Y; Go EP; Dey B; Andine T; Kwon A; Patel M; Gururani D; Uddin F; Guzzo C; Cimbro R; Miao H; McKee K; Chuang GY; Martin L; Sironi F; Malnati MS; Desaire H; Berger EA; Mascola JR; Dolan MA; Kwong PD; Lusso P
    Cell Host Microbe; 2018 Jun; 23(6):832-844.e6. PubMed ID: 29902444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative substitutions of N332 in HIV-1
    Jeffy J; Parthasarathy D; Ahmed S; Cervera-Benet H; Xiong U; Harris M; Mazurov D; Pickthorn S; Herschhorn A
    mBio; 2024 Apr; 15(4):e0268623. PubMed ID: 38470051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.
    Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD
    J Virol; 2017 May; 91(10):. PubMed ID: 28275193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes.
    Das S; Boliar S; Mitra N; Samal S; Bansal M; Koff WC; Chakrabarti BK
    Retrovirology; 2016 Nov; 13(1):81. PubMed ID: 27871328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.